Aikou Okamoto

机构：Jikei University School of Medicine · ORCID：0000-0002-5079-0464

发表论文 619 篇 · 总被引 19789 次 · h-index 53

代表论文

• Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancer (2025 · Annals of Oncology · 被引 12)
• LBA44 Durvalumab + paclitaxel/carboplatin + bevacizumab followed by durvalumab, bevacizumab + olaparib maintenance in patients with newly diagnosed non-tBRCA-mutated advanced ovarian cancer: Final overall survival from DUO-O/ENGOT-ov46/GOG-3025 (2025 · Annals of Oncology · 被引 3)
• Impact of neoadjuvant chemotherapy followed by interval debulking surgery on survival in women with advanced non-serous ovarian, fallopian tube, or primary peritoneal cancer (2025 · Gynecologic Oncology · 被引 2)
• The detrimental impact of diverting ileostomy on renal function after tumor debulking surgery for advanced ovarian cancer (2025 · Gynecologic Oncology · 被引 2)
• Real-world safety and effectiveness of olaparib maintenance after first-relapse platinum-sensitive ovarian cancer in Japan: a multicenter historical cohort (JGOG3026) (2026 · Journal of Gynecologic Oncology)
• Outcome of advanced ovarian cancer patients who do not undergo cytoreductive surgery in the era of PARP inhibitors maintenance therapy: a propensity score-based analysis (2026 · Journal of Gynecologic Oncology)